<p>The present invention is directed to therapeutic agents which are atypical antipsychotics and which are useful in the treatment of neurological and psychiatric disorders associated with dopamine D2 and serotonin 5-HT2A neurotransmission dysfunction.</p>
申请公布号
EP2144905(A1)
申请公布日期
2010.01.20
申请号
EP20080742520
申请日期
2008.04.03
申请人
MERCK & CO., INC.
发明人
BILODEAU, MARK, T.;NANDA, KAUSIK, K.;TROTTER, B. WESLEY
